Enteroviruses and myocardial infarction

American Heart Journal

Volumn 138, Issue 5 II, 1999, Pages

  Roivainen, M ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ANTIBODY RESPONSE; ATHEROGENESIS; CONFERENCE PAPER; CORONARY RISK; DISEASE ASSOCIATION; ENTEROVIRUS INFECTION; FEMALE; FINLAND; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0032718496     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70280-2     Document Type: Conference Paper

References (22)

1. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
2. Sohal RS, Burch GE, Chu KC, et al. Ultrastructural changes in cardiac capillaries of coxsackie virus B4-infected mice. Lab Invest 1968;19:399-405.
3. Woods JD, Nimmo MJ, Mackay-Scollay EM. Acute transmural myocardial infarction associated with active coxsackie virus B infection. Am Heart J 1975;89:283-7.
4. Nicholls AC, Thomas M. Coxsackie virus infection in acute myocardial infarction. Lancet 1977;1:883-4.
5. Nikoskelainen J, Kalliomäki JL, Lapinleimu K, et al. Coxsackie B virus antibodies in myocardial infarction. Acta Med Scand 1983;214:29-32.
6. Grist NR, Bell EJ. A 6-year study of coxsackievirus B infections in heart disease. J Hyg (Camb) 1974;73:165-72.
7. Wood SF, Rogen AS, Bell EJ, et al. Role of coxsackie B viruses in myocardial infarction. Br Heart J 1978;40:523-5.
8. Griffiths PD, Hannington G, Booth JC. Coxsackie B virus infections and myocardial infarction. Lancet 1980;1:1387-9.
9. Woodruff JF. Viral myocarditis: a review. Am J Pathol 1980;101:425-84.
10. Haverkos HW. Could the aetiology of IDDM be multifactorial. Diabetologia 1997;40:1235-40.
11. Roivainen M, Närvänen A, Korkolainen M, et al. Antigenic regions of poliovirus type 3/Sabin capsid proteins recognized by human sera in the peptide scanning technique. Virology 1991;180:99-107.
12. Hovi T, Roivainen M. Peptide antisera targeted to a conserved sequence in poliovirus capsid protein VP1 cross-react widely with members of the genus enterovirus. J Clin Microbiol 1993;31:1083-7.
13. Samuelsson A, Cello J, Skoog E, et al. Enterovirus IgG ELISA using synthetic peptides as antigens. Serodiagn Immunother Infect Dis 1993;5:93-6.
14. Hyöty H, Hiltunen M, Knip M, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995;44:652-7.
15. Davidkin I, Valle M, Peltola H, et al. Etiology of measles- and rubella-like illnesses in measles, mumps and rubella (MMR)-vaccinated children. J Infect Dis 1998;178:1567-70.
16. Roivainen M, Alfthan G, Jousilahti P, et al. Enterovirus infections as a possible risk factor for myocardial infarction. Circulation 1998;98:2534-7.
17. Puska P, Tuomilehto J, Salonen J, et al. The North Karelia Project: evaluation of a comprehensive Community Programme for Control of Cardiovascular Diseases in 1972-1977 in North Karelia, Finland WHO/EURO, Copenhagen 1981.
18. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 1987;317:1237-45.
19. Jousilahti P, Vartiainen E, Tuomilehto J, et al. Twenty-year dynamics of serum cholesterol levels in the middle-aged population of eastern Finland. Ann Intern Med 1996;125:713-22.
20. Friedman HM, Marcarak EJ, MacGregor RR, et al. Virus infection of endothelial cells. J Infect Dis 1981;143:266-73.
21. Wick G, Schett G, Amberger A, et al. Is atherosclerosis an immunologically mediated disease. Immunol Today 1995;16:27-33.
22. Garry RF, Ulug ET, Bose HR Jr. Stress protein induction ocurs in eukaryotic cells following infection by diverse viruses in vitro. Virology 1983;129:319-32.